Laboratory: Anatomic Pathology User Guide

Total Page:16

File Type:pdf, Size:1020Kb

Laboratory: Anatomic Pathology User Guide Laboratory Anatomic Pathology (AP) Version 5.2 User Guide February 2019 Department of Veterans Affairs (VA) Office of Information and Technology (OIT) Product Development (PD) Revision History Date Description (Patch # if applicable) Author 02/2019 LR*5.2*504 HPS Clinical Added Missing AP Alert Search to the Menu Options and Sustainment Team added LRAPALERT section REDACTED 09/2015 LR*5.2*442, Updates for ICD-10 Patient Treatment File REDACTED (PTF) Modifications: • Updated title page, headers, footers, and Revision History. • Corrected styles and spacing issues throughout document. • Reformatted table in Appendix B. • Added text to Tissue Committee Review Cases Option (p.286, 377). 08/2014 LR*5.2*422 – Updates for ICD-10 REDACTED Overall: Ensured all screen captures followed the SSN guidelines specified in Displaying Sensitive Date Guide. Updated Title page Added Revision History (pp i-ii) Changed ICD9 to ICD (pp.3, 18, 192, 196) "FS/Gross/Micro/Dx/ICD Coding [LRAPDGI]" (pp. 84, 360) "Autopsy protocol & ICD coding [LRAPAUDAA]" and "FS/Gross/Micro/Dx/ICD Coding [LRAPDGI]" (p.20) "Autopsy protocol & ICD coding [LRAPAUDAA]" (pp. 40 49, 343,362) ICD Coding, Anat Path [LRAPICD] "Select ICD DIAGNOSIS:" and "FS/Gross/Micro/Dx/ICD Coding [LRAPDGI]" (p. 41) ICD Coding, Anat Path [LRAPICD] "Select ICD DIAGNOSIS:" (pp. 67, 363) 01/2001 Revised. VA OIT 10/1994 Initial document published. VA OIT Laboratory AP User Guide ii February 2019 Preface NOTE: The Veterans Health Information Systems and Architecture (VISTA) Laboratory Anatomic Pathology User’s Manual released in October 1994 has been edited to include an Appendix B section. The appendix contains file, fields, options changes, and examples created by the release of patch LR*5.2*248. The Anatomic Pathology User’s Manual was designed as a training guide and reference manual for Veterans Affairs Medical Center (VAMC) Site Managers, Lab Applications Coordinators, and all users of the Anatomic Pathology module of the Laboratory software application. It should be used in conjunction with other documentation of the Laboratory software application. The manual shows users how to enter, edit, and display information for Cytopathology, Autopsy Pathology, Surgical Pathology, Electron Microscopy, preselected lab test lists, and lists of unverified pathology reports. It also shows how to print reports, path micro/dx modification, cum path data summaries, and preselected lab test lists. Laboratory AP User Guide iii February 2019 Table Of Contents INTRODUCTION ------------------------------------------------------------------------------------------- 2 OVERVIEW OF ANATOMIC PATHOLOGY MODULE ------------------------------------------------------ 2 FUNCTIONALITY --------------------------------------------------------------------------------------------- 3 ORIENTATION --------------------------------------------------------------------------------------------- 5 BEFORE YOU BEGIN ---------------------------------------------------------------------------------------- 5 SPECIAL KEYS, COMMANDS, AND CONVENTIONS ------------------------------------------------------ 5 MANUAL CONVENTIONS ----------------------------------------------------------------------------------- 8 PACKAGE MANAGEMENT---------------------------------------------------------------------------- 10 PACKAGE OPERATIONS ------------------------------------------------------------------------------ 12 ANATOMIC PATHOLOGY MENU -------------------------------------------------------------------------- 12 Menu Descriptions ------------------------------------------------------------------------------------- 13 Anatomic Pathology Menus --------------------------------------------------------------------------- 15 WORKFLOW ------------------------------------------------------------------------------------------------- 21 A. Log-in --------------------------------------------------------------------------------------------- 21 B. Data Entry ---------------------------------------------------------------------------------------- 21 C. Final Reports ------------------------------------------------------------------------------------- 22 Summary of Selected AP Options -------------------------------------------------------------------- 24 SNOMED CODING/SEARCHES --------------------------------------------------------------------------- 25 Reports --------------------------------------------------------------------------------------------------- 28 Frozen Sections -------------------------------------------------------------------------------------- 28 Bone Marrows --------------------------------------------------------------------------------------- 28 Autopsy ----------------------------------------------------------------------------------------------- 29 ANATOMIC PATHOLOGY MENU OPTIONS ---------------------------------------------------- 33 DATA ENTRY, ANAT PATH [LRAPD] ------------------------------------------------------------------- 34 Descriptions --------------------------------------------------------------------------------------------- 34 Data entry for Autopsies [LRAPAUDA] -------------------------------------------------------- 34 Coding ------------------------------------------------------------------------------------------------ 35 Data Entry for Autopsies [LRAPAUDA] ----------------------------------------------------------- 37 Provisional Anatomic Diagnoses [LRAPAUPAD] -------------------------------------------- 37 Autopsy Protocol [LRAPAUDAP] --------------------------------------------------------------- 39 Autopsy Protocol and SNOMED Coding [LRAPAUDAB] ---------------------------------- 40 Laboratory AP User Guide iv February 2019 Autopsy Protocol and ICD Coding [LRAPAUDAA] ------------------------------------------ 48 Final Autopsy Diagnoses Date [LRAPAUFAD] ----------------------------------------------- 50 Autopsy Supplementary Report [LRAPAUSR] ----------------------------------------------------- 51 Autopsy [LRAPAUDAS] -------------------------------------------------------------------------- 53 Blocks, Stains, Procedures, Anat Path [LRAPSPDAT] ------------------------------------------- 56 Surgical Pathology ---------------------------------------------------------------------------------- 56 Cytology ---------------------------------------------------------------------------------------------- 56 Electron Microscopy -------------------------------------------------------------------------------- 56 Autopsy ----------------------------------------------------------------------------------------------- 56 General ------------------------------------------------------------------------------------------------ 57 Example 1: Routine Data Entry for Surg Path (workload off) ------------------------------ 57 Example 2: Routine Data Entry for Surgical Pathology Frozen Section ------------------ 59 Example 3: Editing Data for Cytology --------------------------------------------------------- 62 (data already entered based on workload profiles) --------------------------------------------- 62 Example 4: Data Entry for EM ------------------------------------------------------------------ 65 Example 5: Date/Times are not in Sequence -------------------------------------------------- 67 Example 6: More than one Specimen ---------------------------------------------------------- 69 Coding, Anat Path [LRAPCODE] ------------------------------------------------------------------- 71 SNOMED Coding, Anat Path [LRAPX]--------------------------------------------------------- 71 ICD Coding, Anat Path [LRAPICD] ------------------------------------------------------------- 72 Clinical HX/Gross Description [LRAPDGD] ------------------------------------------------------ 74 Example 1: Entry of Information for a Surgical Pathology/ -------------------------------- 75 ASK FROZEN SECTION set to NO ------------------------------------------------------------- 75 Example 2: Entry of Information for a Surgical Pathology Specimen with a ------------ 76 Frozen Section ASK FROZEN SECTION set to YES ---------------------------------------- 76 FS/Gross/Micro/Dx [LRAPDGM] ------------------------------------------------------------------- 78 FS/Gross/Micro/DX/SNOMED Coding [LRAPDGS] --------------------------------------------- 81 Example 2: Entry of Information for a Surgical Pathology Specimen -------------------- 85 with a Frozen Section ------------------------------------------------------------------------------- 85 Example 3: Using a Template to enter a Bone Marrow Report ---------------------------- 87 Example 4: Using a Template to Enter a Bethesda system Report for a Cytology ------ 95 FS/Gross/Micro/Dx ICD [LRAPDGI] -------------------------------------------------------------- 97 Enter Old Anat Path Records [LRAPOLD] -------------------------------------------------------- 99 Laboratory AP User Guide v February 2019 Supplementary Report, Anat Path [LRAPDSR] ------------------------------------------------- 101 Special Studies-EM;Immuno;Consult;pic, Anat Path [LRAPDSS] --------------------------- 104 Edit/Modify Data, Anat Path [LRAPE] ----------------------------------------------------------- 106 Description ----------------------------------------------------------------------------------------- 106 Edit Log-In & Clinical Hx Anat Path [LRAPED] ----------------------------------------------- 107 Modify Anat Path Gross/Micro/Dx/Frozen Sections [LRAPM] ------------------------------- 110 Example 1: Modify Anat Path Gross/Micro/Dx/Frozen
Recommended publications
  • Medical Directors Arup Medical Directors and Consulting Faculty | 2015
    MEDICAL DIRECTORS ARUP MEDICAL DIRECTORS AND CONSULTING FACULTY | 2015 MAY 2015 www.aruplab.com Information in this brochure is current as of May 2015. All content is subject to change. Please contact ARUP Client Services at (800) 522-2787 with any questions or concerns. ARUP LABORATORIES ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. Located in Salt Lake City, Utah, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. Rather than competing with its clients for physician office business, ARUP chooses instead to support clients’ existing test menus by offering complex and unique tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services. ARUP’s clients include many of the nation’s university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. Since its formation in 1984 by the Department of Pathology at the University of Utah, ARUP has founded its reputation on reliable and consistent laboratory testing and service. This simple strategy contributes significantly to client satisfaction. When ARUP conducts surveys, clients regularly rate ARUP highly and respond that they would recommend ARUP to others. As the most responsive source of quality information and knowledge, ARUP strives to be the reference laboratory of choice for community healthcare systems.
    [Show full text]
  • A Practical Handbook for Determining the Ages of Gulf of Mexico And
    A Practical Handbook for Determining the Ages of Gulf of Mexico and Atlantic Coast Fishes THIRD EDITION GSMFC No. 300 NOVEMBER 2020 i Gulf States Marine Fisheries Commission Commissioners and Proxies ALABAMA Senator R.L. “Bret” Allain, II Chris Blankenship, Commissioner State Senator District 21 Alabama Department of Conservation Franklin, Louisiana and Natural Resources John Roussel Montgomery, Alabama Zachary, Louisiana Representative Chris Pringle Mobile, Alabama MISSISSIPPI Chris Nelson Joe Spraggins, Executive Director Bon Secour Fisheries, Inc. Mississippi Department of Marine Bon Secour, Alabama Resources Biloxi, Mississippi FLORIDA Read Hendon Eric Sutton, Executive Director USM/Gulf Coast Research Laboratory Florida Fish and Wildlife Ocean Springs, Mississippi Conservation Commission Tallahassee, Florida TEXAS Representative Jay Trumbull Carter Smith, Executive Director Tallahassee, Florida Texas Parks and Wildlife Department Austin, Texas LOUISIANA Doug Boyd Jack Montoucet, Secretary Boerne, Texas Louisiana Department of Wildlife and Fisheries Baton Rouge, Louisiana GSMFC Staff ASMFC Staff Mr. David M. Donaldson Mr. Bob Beal Executive Director Executive Director Mr. Steven J. VanderKooy Mr. Jeffrey Kipp IJF Program Coordinator Stock Assessment Scientist Ms. Debora McIntyre Dr. Kristen Anstead IJF Staff Assistant Fisheries Scientist ii A Practical Handbook for Determining the Ages of Gulf of Mexico and Atlantic Coast Fishes Third Edition Edited by Steve VanderKooy Jessica Carroll Scott Elzey Jessica Gilmore Jeffrey Kipp Gulf States Marine Fisheries Commission 2404 Government St Ocean Springs, MS 39564 and Atlantic States Marine Fisheries Commission 1050 N. Highland Street Suite 200 A-N Arlington, VA 22201 Publication Number 300 November 2020 A publication of the Gulf States Marine Fisheries Commission pursuant to National Oceanic and Atmospheric Administration Award Number NA15NMF4070076 and NA15NMF4720399.
    [Show full text]
  • Gender and the Quest in British Science Fiction Television CRITICAL EXPLORATIONS in SCIENCE FICTION and FANTASY (A Series Edited by Donald E
    Gender and the Quest in British Science Fiction Television CRITICAL EXPLORATIONS IN SCIENCE FICTION AND FANTASY (a series edited by Donald E. Palumbo and C.W. Sullivan III) 1 Worlds Apart? Dualism and Transgression in Contemporary Female Dystopias (Dunja M. Mohr, 2005) 2 Tolkien and Shakespeare: Essays on Shared Themes and Language (ed. Janet Brennan Croft, 2007) 3 Culture, Identities and Technology in the Star Wars Films: Essays on the Two Trilogies (ed. Carl Silvio, Tony M. Vinci, 2007) 4 The Influence of Star Trek on Television, Film and Culture (ed. Lincoln Geraghty, 2008) 5 Hugo Gernsback and the Century of Science Fiction (Gary Westfahl, 2007) 6 One Earth, One People: The Mythopoeic Fantasy Series of Ursula K. Le Guin, Lloyd Alexander, Madeleine L’Engle and Orson Scott Card (Marek Oziewicz, 2008) 7 The Evolution of Tolkien’s Mythology: A Study of the History of Middle-earth (Elizabeth A. Whittingham, 2008) 8 H. Beam Piper: A Biography (John F. Carr, 2008) 9 Dreams and Nightmares: Science and Technology in Myth and Fiction (Mordecai Roshwald, 2008) 10 Lilith in a New Light: Essays on the George MacDonald Fantasy Novel (ed. Lucas H. Harriman, 2008) 11 Feminist Narrative and the Supernatural: The Function of Fantastic Devices in Seven Recent Novels (Katherine J. Weese, 2008) 12 The Science of Fiction and the Fiction of Science: Collected Essays on SF Storytelling and the Gnostic Imagination (Frank McConnell, ed. Gary Westfahl, 2009) 13 Kim Stanley Robinson Maps the Unimaginable: Critical Essays (ed. William J. Burling, 2009) 14 The Inter-Galactic Playground: A Critical Study of Children’s and Teens’ Science Fiction (Farah Mendlesohn, 2009) 15 Science Fiction from Québec: A Postcolonial Study (Amy J.
    [Show full text]
  • Role of the Microbiology Laboratory in Infection Control
    GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 3: Role of the Microbiology Laboratory in Infection Control Author Mohamed Benbachir, PhD Chapter Editor Gonzalo Bearman MD, MPH, FACP, FSHEA, FIDSA Topic Outline Key Issues Known Facts Suggested Practice Suggested Practice in Under-Resourced Settings Summary References Chapter last updated: January, 2018 KEY ISSUES The microbiology laboratory plays an important role in the surveillance, treatment, control and prevention oF nosocomial inFections. The microbiologist is a permanent and active member oF the infection control committee (ICC) and the antimicrobial stewardship group (ASG). Since most of the inFection control and antimicrobial stewardship programs rely on microbiological results, quality assurance is an important issue. KNOWN FACTS The microbiologist is a daily privileged interlocutor oF the infection control team (inFection control doctor and inFection control nurse) and the antimicrobial stewardship working group. The First task oF the microbiology laboratory is to accurately, consistently and rapidly identiFy the responsible agents to species level and identify their antimicrobial resistance patterns. Traditional microbiologic methods remain suboptimal in providing rapid identification and susceptibility testing. There is a growing need for more rapid and reliable laboratory results. Important progress made in the fields of instruments, reagents and techniques have made it easier to adapt to the important changes oF the clinical microbiology context e.g. increasing use of microbiology tests, shortage of qualiFied personnel. There is also a growing demand For quality in clinical laboratories and more and more countries are elaborating national regulations. 1 The microbiology processes are becoming increasingly more complex. InFormatics are playing an increasing role in the improvement oF these processes in terms oF workFlow, timeliness and cost.
    [Show full text]
  • Cava of Toledo; Or, the Gothic Princess
    Author: Augusta Amelia Stuart Title: Cava of Toledo; or, the Gothic Princess Place of publication: London Publisher: Printed at the Minerva-Press, for A. K. Newman and Co. Date of publication: 1812 Edition: 1st ed. Number of volumes: 5 CAVA OF TOLEDO. A ROMANCE. Lane, Darling, and Co. Leadenhall-Street. CAVA OF TOLEDO; OR, The Gothic Princess. A ROMANCE. IN FIVE VOLUMES BY AUGUSTA AMELIA STUART, AUTHOR OF LUDOVICO’S TALE; THE ENGLISH BROTHERS; EXILE OF PORTUGAL, &c. &c. Fierce wars, and faithful loves, And truths severe, in fairy fiction drest. VOL. I. LONDON: PRINTED AT THE Minerva Press, FOR A. K. NEWMAN AND CO. LEADENHALL-STREET. 1812. PREFACE. THE author of the following sheets, struck by the account historians have given of the fall of the Gothic empire in Spain, took the story of Cava for the foundation of a romance: whether she has succeeded or not in rendering it interesting, must be left to her readers to judge. She thinks it, however, necessary to say she has not falsified history; all relating to the war is exact: the real characters she has endeavoured to delineate such as they were; —Rodrigo—count Julian—don Palayo—Abdalesis, the Moor—queen Egilone—Musa—and Tariff, are drawn as the Spanish history represents them. Cava was never heard of from her quitting Spain with her father; of course, her adventures, from that period, are the coinage of the author’s brain. The enchanted palace, which Rodrigo broke into, is mentioned in history. Her fictitious characters she has moulded to her own will; and has found it a much more difficult task than she expected, to write an historical romance, and adhere to the truth, while she endeavoured to embellish it.
    [Show full text]
  • Health Sciences Center
    Faculty of Allied Health Sciences Handbook: 2020-2021 KUWAIT UNIVERSITY HEALTH SCIENCES CENTRE 1 | P a g e KUWAIT UNIVERSITY HEALTH SCIENCES CENTRE FACULTY OF ALLIED HEALTH SCIENCES Established: 1982 HANDBOOK 2020-2021 2 | P a g e Department of MEDICAL LABORATORY SCIENCES [MLS] 3 | P a g e DEPARTMENT OF MEDICAL LABORATORY SCIENCES Medical Laboratory Sciences offers opportunities for those interested in biological and chemical sciences, leading to a career in the health service or in research. Medical laboratory scientists are professionals who perform laboratory tests and analyses that assist physicians in the diagnosis and treatment of patients. They also assist in research and the development of new laboratory tests. The various studies include chemical and physical analysis of body fluids (clinical chemistry and urinalysis); examination of blood and its component cells (haematology); isolation and identification of bacteria, fungi, viruses and parasites (clinical microbiology and parasitology); testing of blood serum for antibodies indicative of specific diseases (immunology and serology) and collection, storage of blood, pretransfusion testing and other immunohaematological procedures (blood banking). In addition, medical laboratory scientists prepare tissues for histopathological, cytological and cytogenetic examination. They must know the theory and scientific fundamentals as well as the procedures for testing. Medical laboratory scientists work in hospital clinical laboratories, medical schools, research institutions, public health agencies and related organizations. MISSION AND OBJECTIVES Mission The mission of the Department of Medical Laboratory Sciences is to educate and train skillful, knowledgeable and committed Medical Laboratory Scientists who have breadth of knowledge and competence in the various aspects of Medical Laboratory Sciences, who shall adhere to professional ethics, and who can contribute successfully as Medical Laboratory Scientists in the health care team.
    [Show full text]
  • Understanding Your Pathology Report: Benign Breast Conditions
    cancer.org | 1.800.227.2345 Understanding Your Pathology Report: Benign Breast Conditions When your breast was biopsied, the samples taken were studied under the microscope by a specialized doctor with many years of training called a pathologist. The pathologist sends your doctor a report that gives a diagnosis for each sample taken. Information in this report will be used to help manage your care. The questions and answers that follow are meant to help you understand medical language you might find in the pathology report from a breast biopsy1, such as a needle biopsy or an excision biopsy. In a needle biopsy, a hollow needle is used to remove a sample of an abnormal area. An excision biopsy removes the entire abnormal area, often with some of the surrounding normal tissue. An excision biopsy is much like a type of breast-conserving surgery2 called a lumpectomy. What does it mean if my report uses any of the following terms: adenosis, sclerosing adenosis, apocrine metaplasia, cysts, columnar cell change, columnar cell hyperplasia, collagenous spherulosis, duct ectasia, columnar alteration with prominent apical snouts and secretions (CAPSS), papillomatosis, or fibrocystic changes? All of these are terms that describe benign (non-cancerous) changes that the pathologist might see under the microscope. They do not need to be treated. They are of no concern when found along with cancer. More information about many of these can be found in Non-Cancerous Breast Conditions3. What does it mean if my report says fat necrosis? Fat necrosis is a benign condition that is not linked to cancer risk.
    [Show full text]
  • Clinical Microbiology Core Rotation
    C:\Documents and Settings\jdnoll\Desktop\UofFCytolRot10.doc CYTOPATHOLOGY ROTATION Site: University of Florida-Gainesville/ Shands North & South Tower Faculty: Peter Drew, M.D. (4-4969) Larry J. Fowler, M.D., Cytology Director (4-4959) Jacquelyn Knapik, M.D. (4-3887) Li Lu, M.D, PhD (63-6440) Demaretta Rush, M.D. (5-3364) Edward Wilkinson, M.D. (4-4962) Anthony Yachnis, M.D., Anatomic Pathology Director (4-4951) Current Cytopathology Fellow Charlene M. Lewis, CT (ASCP) Superviser Deborah A. Carroll, CT, (ASCP) Patricia Christensen, CT (ASCP) David A. Lemire, CT (ASCP) Rotation Periods: 12 weeks for CORE Rotation broken into three 4 week rotations (a portion of the 12 weeks may be on the VA Hospital Cytology Rotation). Offered all 12 months of any training year. I. General Organization: The cytopathology core rotation consists of three 4 week rotations (total 12 weeks) routinely placed within the 1st thru 4th PGY training years of a 4 year APCP training program. The CORE rotation may also be done in one combined 12 week rotation upon special request. Cervical biopsies and local gynecologic excisions are signed out in tandem with cytology specimens (correlation of surgical and cytologic specimens). The first 4 week's rotation, residents review the day's cases at the time of sign-out with the faculty member on service. During the second and third 4 week rotations residents preview cases before sign-out, render preliminary interpretations, and receive feedback at sign out (graduated responsibility). Fellows preview the slides before sign-out and render interpretations, and have the option to attend sign-out or receive feedback from the attending pathologist later (graduated responsibility).
    [Show full text]
  • Year 11 GCSE History Paper 1 – Medicine Information Booklet
    Paper 1 Medicine Key topics 1 and 2 (1250-1500, 1500-1700) Year 11 GCSE History Paper 1 – Medicine Information booklet Medieval Renaissance 1250-1500 1500-1750 Enlightenment Modern 1900-present 1700-1900 Case study: WW1 1 Paper 1 Medicine Key topics 1 and 2 (1250-1500, 1500-1700) Key topic 1.1 – Causes of disease 1250-1500 At this time there were four main ideas to explain why someone might become ill. Religious reasons - The Church was very powerful at this time. People would attend church 2/3 times a week and nuns and monks would care for people if they became ill. The Church told people that the Devil could infect people with disease and the only way to get better was to pray to God. The Church also told people that God could give you a disease to test your faith in him or sometimes send a great plague to punish people for their sins. People had so much belief in the Church no-one questioned the power of the Church and many people had believed this explanation of illness for over 1,000 years. Astrology -After so many people in Britain died during the Black Death (1348-49) people began to look for new ways to explain why they became sick. At this time doctors were called physicians. They would check someone’s urine and judge if you were ill based on its colour. They also believed they could work out why disease you had by looking at where the planets were when you were born.
    [Show full text]
  • Cytopathology Fellowship Faculty of Medicine, Postgraduate Medical Education
    Cytopathology Fellowship Faculty of Medicine, Postgraduate Medical Education Institution: McGill University and McGill University Health Centre Location: Department of Pathology, MUHC and Duff Medical Building Type of Fellowship: One year clinical fellowship in Cytopathology Fellowship Program Director: Dr. Manon Auger Program Information Number of fellowship positions requested: One Academic affiliation: McGill University Name of hospitals involved in training: McGill University Health Centre (MUHC) Background: The fellowship will be principally based at the MUHC. This one-year post-residency clinical fellowship offers a comprehensive, integrated exposure to the field of Cytopathology. The cytological specimens handled at the MUHC include approximately 50,000 gynecological specimens per year (including approximately 7000 colposcopic specimens) as well as 10,000 non-gynecological specimens (including approximately 4000 fine needle aspirates). Exposure to liquid- based cytology is provided. Research activity and publications: The fellow will be expected to participate in at least one major research project involving, at minimum, a review of a series of cases (i.e., not simply a case report) with a view to publication in a peer-reviewed journal (i.e. not only presentation at a meeting). In addition, other research projects may be carried out, including case reports. Mission and objectives: The general mission of the fellowship is to provide training in the interpretation of cytopathology with a view to learn the entire spectrum of reactive
    [Show full text]
  • Simple Technique to Identify Haemosiderin in Immunoperoxidase Stained Sections
    J Clin Pathol: first published as 10.1136/jcp.37.10.1190 on 1 October 1984. Downloaded from 1190 Technical methods Phosphate buffer at pH 8*0 gave the sharpest 2 Rozenszajn L, Leibovich M, Shoham D, Epstein J. The esterase staining reactions, although there was little differ- activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol 1968; 14:605-19. ence at pH 7-0 or pH 7-5. As the buffer pH was 3Hayhoe FGJ, Quaglino D. Haematological cytochemistry. Edin- increased above pH 8-0 staining with both substrates burgh: Churchill Livingstone, 1980. became progressively weaker, especially above pH 4Li CY, Lam KW, Yam LT. Esterases in human leucocytes. J 9.0. Below pH 7-0 staining with a-naphthyl butyrate Histochem Cytochem 1973;21:1-12. Yam LT, Li CY, Crosby WH. Cytochemical identification of became weaker, and below pH 5*0 staining with monocytes and granulocytes. Am J Clin Pathol 1971;55:283- naphthol AS-D chloroacetate began to disappear. 90. 6 Armitage RJ, Linch DC, Worman CP, Cawley JC. The morphol- This work was supported by a Medical Research ogy and cytochemistry of human T-cell subpopulations defined by monoclonal antibodies and Fc receptors. Br J Haematol Council project grant. I thank Professor FGJ 1983;51:605-13. Hayhoe for valuable advice. References Requests for reprints to: Dr DM Swirsky, Department of Gomori G. Chloroacyl esters as histochemical substrates. J His- Haematological Medicine, University Clinical School, Hills tochem Cytochem 1953;1:469-70. Road, Cambridge CB2 2QL, England. Simple technique to identify identification of the two compounds on the same haemosiderin in slide.
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]